Tag Archive for: Pliant Therapeutics

Pliant seeks $175 M raise on heels of promising mid-stage IPF data

,

Company president and CEO Bernard Coulie, M.D., Ph.D. called the data “unprecedented in IPF clinical drug development”.

Read more
/by